THC Farmaceuticals, Inc.
CBDG
$0.013
-$0.0011-7.80%
OTC PK
| 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | |
|---|---|---|---|---|---|
| Revenue | 2.27% | -2.04% | -12.00% | 4.35% | -2.22% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.27% | -2.04% | -12.00% | 4.35% | -2.22% |
| Cost of Revenue | 66.67% | 66.67% | -40.48% | -35.71% | -35.71% |
| Gross Profit | -100.00% | -86.36% | 137.50% | 425.00% | 466.67% |
| SG&A Expenses | 780.00% | 390.00% | -23.13% | 155.88% | 0.00% |
| Depreciation & Amortization | 0.00% | 200.00% | 0.00% | 0.00% | -33.33% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 478.26% | 253.62% | -27.53% | 49.35% | -18.82% |
| Operating Income | -1,316.00% | -875.00% | 33.59% | -112.50% | 39.02% |
| Income Before Tax | -730.23% | -450.00% | 40.14% | -95.45% | 18.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -730.23% | -450.00% | 40.14% | -95.45% | 18.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -730.23% | -450.00% | 40.14% | -95.45% | 18.87% |
| EBIT | -1,316.00% | -875.00% | 33.59% | -112.50% | 39.02% |
| EBITDA | -1,430.43% | -921.05% | 33.33% | -120.00% | 39.47% |
| EPS Basic | -380.00% | -550.00% | 56.25% | -100.00% | 16.67% |
| Normalized Basic EPS | -400.00% | -300.00% | 60.00% | -100.00% | 25.00% |
| EPS Diluted | -380.00% | -550.00% | 56.25% | -100.00% | 16.67% |
| Normalized Diluted EPS | -400.00% | -300.00% | 60.00% | -100.00% | 25.00% |
| Average Basic Shares Outstanding | 67.22% | 0.00% | 33.49% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 67.22% | 0.00% | 33.49% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |